(Q48608961)

13 February 2018

title

Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats. (English)

1 reference

13 February 2018

author

Marcello Solinas

1

1 reference

13 February 2018

Zuzana Justinova

3

1 reference

13 February 2018

author name string

Leigh V Panlilio

2

1 reference

13 February 2018

Sevil Yasar

4

1 reference

13 February 2018

Steven R Goldberg

5

1 reference

13 February 2018

publication date

1 January 2006

1 reference

13 February 2018

published in

Nature Protocols

1 reference

13 February 2018

volume

1

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

page(s)

1194-1206

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1038/nprot.2006.167

exact match

0 references

cites work

Drug discrimination procedures: differential characteristics of the drug A vs drug B and the drug A vs drug B vs no drug cases.

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Nicotine trace discrimination in rats with midazolam as a mediating stimulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Drug trace discrimination with nicotine and morphine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Drug discrimination in neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Caffeine as a model drug of abuse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Is dopamine important in nicotine dependence?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Cannabis: discrimination of "internal bliss"?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

THE ADDICTION RESEARCH CENTER INVENTORY: STANDARDIZATION OF SCALES WHICH EVALUATE SUBJECTIVE EFFECTS OF MORPHINE, AMPHETAMINE, PENTOBARBITAL, ALCOHOL, LSD-25, PYRAHEXYL AND CHLORPROMAZINE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Drug discrimination by humans compared to nonhumans: current status and future directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Pharmacology of drug self-administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Conditioned place preference: what does it add to our preclinical understanding of drug reward?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Investigations on drug produced and subjectively experienced discriminative stimuli. 2. Loperamide, an antidiarrheal devoid of narcotic cue producing actions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Nucleus accumbens shell and core dopamine: differential role in behavior and addiction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Drug-activation of brain reward pathways.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

The discriminability of apsirin in arthritic and nonarthritic rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Fentanyl and apomorphine: asymmetrical generalization of discriminative stimulus properties.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Discovering risperidone: the LSD model of psychopathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: a variable dose paradigm.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Increased naloxone reversibility in fentanyl dose-dose discrimination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

OR discrimination: a new drug discrimination method.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Drug mixtures and ethanol as compound internal stimuli.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Transition from moderate to excessive drug intake: change in hedonic set point.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Evidence for addiction-like behavior in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Drug seeking becomes compulsive after prolonged cocaine self-administration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Evaluation of deprenyl for cocaine-like discriminative stimulus effects in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Conditioned taste aversions as a behavioral baseline for drug discrimination learning: an assessment with phencyclidine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Three-choice drug discrimination: phencyclidine-like stimulus effects of opioids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Differential haloperidol effect on two indices of fentanyl-saline discrimination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Amphetamine-like effect of l-deprenyl (selegiline) in drug discrimination studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

T-maze and food reinforcement: an inexpensive drug discrimination procedure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Inter-animal olfactory cues in operant drug discrimination procedures in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

Neurobiology of addiction. Toward the development of new therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

inferred from DOI database lookup

7 January 2021

based on heuristic

Interoceptive sensory signals produced by 24-hr food deprivation, pharmacological glucoprivation, and lipoprivation.

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.167

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NPROT.2006.167

1 reference

13 February 2018

1 reference

13 February 2018